Pilot Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization

Description:

Subjects will receive HBOT daily for 10 days in conjunction with standard growth factor
treatment regimens for stem cell mobilization. The role of HBOT in stem cell mobilization as
well as its role on oxidative stress will be evaluated.

Condition:

Multiple Myeloma

Treatment:

Hyperbaric Oxygen Therapy

Start Date:

February 2012

Sponsor:

University of Arkansas

For More Information:

https://clinicaltrials.gov/show/NCT01449539